Implements ISO 14971:2019 risk management processes for medical devices, including hazard identification, FMEA/FTA analysis, risk evaluation matrices, and post-production surveillance. It generates structured risk management plans, hazard worksheets, and risk control strategies compliant with EU MDR and international standards.
Quality gate: INCONCLUSIVE · better answers · measured 2026-10-24 Blind-judged against the bare model on 2 requests: average lift -0.5 points (specificity, structure, method, fit). won 1/2, lift -0.5, tokens ×34.49
Security scan: clean · 2026-10-24 · 6 files · ran in sandbox no network calls, shell tricks, credential access or instruction tampering found in its files.
Try asking
Say it in your own words; the assistant finds this recipe by itself. Examples:
“Lav en risikostyringsplan til vores nye Class IIa infusionspumpe. Den skal indeholde risikomatricen og en RACI-overblik over ansvarlige.”
“Jeg skal lave en FMEA på batterimodulen i vores bærbare defibrillator. Kan du hjælpe mig med at identificere fejlmønstre og vurdere sværhedsgrad?”
“Gennemgå min fareanalyse for den kirurgiske robotarm. Er alle mekaniske og elektriske farer dækket i henhold til ISO 14971?”
“Create a risk management plan for a new Class IIa infusion pump, including the risk acceptability matrix and responsibility assignments.”
“I need to perform a FMEA on the battery module of our portable defibrillator. Can you help me identify potential failure modes and assign severity and probability scores?”
“Review my hazard analysis worksheet for the surgical robot arm. Are all mechanical and electrical hazards covered according to ISO 14971?”
Try this skill from Claude, ChatGPT or a chat on your own page. Free plan, no credit card.Get started free
Do not use this skill for general software security audits or cybersecurity risk assessments that do not involve medical device hardware or patient safety hazards. It is not intended for financial risk management, project management risk logs, or non-medical industrial safety standards (e.g., OSHA general industry) unless specifically tied to a medical device context.
Details
When it is the right choice
Use this skill when the user needs to perform or document risk management activities for a medical device according to ISO 14971. It is appropriate for creating risk management plans, conducting FMEA or FTA, defining risk acceptability criteria, or analyzing post-market safety data. It is also suitable for ensuring compliance with EU MDR requirements regarding risk reduction (AFAP).
The full recipe the assistant reads
Risk Management Specialist
ISO 14971:2019 risk management implementation throughout the medical device lifecycle.
Validation: Plan approved; acceptability criteria defined; responsibilities assigned; file established
Risk Management Plan Content
Section
Content
Evidence
Scope
Device and lifecycle coverage
Scope statement
Criteria
Risk acceptability matrix
Risk matrix document
Responsibilities
Roles and authorities
RACI chart
Verification
Methods and acceptance
Verification plan
Production/Post-Production
Monitoring activities
Surveillance plan
Risk Acceptability Matrix (5x5)
Probability \ Severity
Negligible
Minor
Serious
Critical
Catastrophic
Frequent (P5)
Medium
High
High
Unacceptable
Unacceptable
Probable (P4)
Medium
Medium
High
High
Unacceptable
Occasional (P3)
Low
Medium
Medium
High
High
Remote (P2)
Low
Low
Medium
Medium
High
Improbable (P1)
Low
Low
Low
Medium
Medium
Risk Level Actions
Level
Acceptable
Action Required
Low
Yes
Document and accept; still reduce as far as possible (EU MDR)
Medium
After reduction AFAP
Reduce as far as possible; document why further reduction is impossible
High
After reduction AFAP
Reduction required; demonstrate all further options exhausted
Unacceptable
No
Design change mandatory
EU MDR — AFAP, not ALARP: For CE-marked devices, risks must be reduced as far as possible (AFAP) without economic considerations (MDR Annex I, GSPR 1–4; EN ISO 14971:2019/A11:2021 Z-annexes deviation). ALARP ("as low as reasonably practicable"), which permits cost-benefit weighing in acceptability decisions, is not an acceptable criterion under the EU MDR — a notified body will flag it. ISO 14971:2019 itself removed ALARP from the normative text. ALARP may persist in some non-EU jurisdictions (e.g., the UK HSE tradition); if used outside the EU, flag the deviation from EU requirements explicitly.
Risk Analysis Workflow
Identify hazards and estimate risks systematically.
Workflow: Conduct Risk Analysis
Define intended use and reasonably foreseeable misuse:
Medical indication
Patient population
User population
Use environment
Select analysis method(s):
FMEA for component/function analysis
FTA for system-level analysis
HAZOP for process deviations
Use Error Analysis for user interaction
Identify hazards by category:
Energy hazards (electrical, mechanical, thermal)
Biological hazards (bioburden, biocompatibility)
Chemical hazards (residues, leachables)
Operational hazards (software, use errors)
Determine hazardous situations:
Sequence of events
Foreseeable misuse scenarios
Single fault conditions
Estimate probability of harm (P1-P5)
Estimate severity of harm (S1-S5)
Document in hazard analysis worksheet
Validation: All hazard categories addressed; all hazards documented; probability and severity assigned
Calculate initial risk level from probability × severity
Compare to risk acceptability criteria
For each risk, determine:
Acceptable: Document and accept (EU MDR: still reduce as far as possible)
Reduction required (AFAP): Proceed to risk control
Unacceptable: Mandatory risk control
Document evaluation rationale
Identify risks requiring benefit-risk analysis
Complete benefit-risk analysis if applicable
Compile risk evaluation summary
Validation: All risks evaluated; acceptability determined; rationale documented
Risk Evaluation Decision Tree
Risk Estimated
│
▼
Apply Acceptability Criteria
│
├── Low Risk ──────────► Accept and document
│
├── Medium Risk ───────► Reduce as far as possible (AFAP)
│ │ Document why further reduction impossible
│ ▼
│ Further reduction possible?
│ │
│ Yes──► Implement control
│ No───► Document AFAP rationale (no economic considerations)
│
├── High Risk ─────────► Risk reduction required
│ │ Must demonstrate reduction AFAP
│ ▼
│ Implement control
│ Verify residual risk
│
└── Unacceptable ──────► Design change mandatory
Cannot proceed without control
AFAP Demonstration Requirements (EU MDR)
Criterion
Evidence Required
All control options considered
Analysis of every feasible control per the hierarchy (design, protective measures, information)
Further reduction impossible
Evidence each remaining option is technically infeasible or does not further reduce risk
State of the art
Comparison to similar devices and current standards
Stakeholder input
Clinical/user perspectives
Economic considerations (cost of further risk reduction) must not enter the EU acceptability decision (MDR Annex I GSPR 2; EN ISO 14971:2019/A11:2021). Cost may inform business decisions about whether to market the device — never whether a risk is acceptable.
Benefit-Risk Analysis Triggers
Situation
Benefit-Risk Required
Residual risk remains high
Yes
No feasible risk reduction
Yes
Novel device
Yes
Unacceptable risk with clinical benefit
Yes
All risks low
No
Risk Control Workflow
Implement and verify risk control measures.
Workflow: Implement Risk Controls
Identify risk control options:
Inherent safety by design (Priority 1)
Protective measures in device (Priority 2)
Information for safety (Priority 3)
Select optimal control following hierarchy
Analyze control for new hazards introduced
Document control in design requirements
Implement control in design
Develop verification protocol
Execute verification and document results
Evaluate residual risk with control in place
Validation: Control implemented; verification passed; residual risk acceptable; no unaddressed new hazards